FEMS Immunol Med Microbiol. 2001 Feb;30(1):49-52.

Oral probiotics can resolve urogenital infections.

Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B.

Source

Lawson Research Institute, London, Ont., Canada. gregor@julian.uwo.ca

Abstract

We report the first clinical evidence that probiotic lactobacilli can be delivered to the vagina following oral intake. In 10 women with a history of recurrent yeast vaginitis, bacterial vaginosis (BV) and urinary tract infections, strains Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14 suspended in skim milk and given twice daily for 14 days, were recovered from the vagina and identified by morphology and molecular typing within 1 week of commencement of therapy. In six cases of asymptomatic BV or intermediate BV (based upon Nugent scoring) was resolved within 1 week of therapy.

PMID:: 11172991; [PubMed - indexed for MEDLINE]

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. [Microbes Infect. 2006]
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G. Microbes Infect. 2006 May; 8(6):1450-4. Epub 2006 Mar 29.
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. [Microbes Infect. 2006]
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Microbes Infect. 2006 Oct; 8(12-13):2772-6. Epub 2006 Sep 11.
Review Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. [Clin Ther. 2008]
Review Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R, Tassone D. Clin Ther. 2008 Mar; 30(3):453-68.
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. [FEMS Immunol Med Microbiol. 2003]
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. FEMS Immunol Med Microbiol. 2003 Mar 20; 35(2):131-4.
Review Probiotics for the treatment of women with bacterial vaginosis. [Clin Microbiol Infect. 2007]
Review Probiotics for the treatment of women with bacterial vaginosis.
Falagas M, Betsi GI, Athanasiou S. Clin Microbiol Infect. 2007 Jul; 13(7):657-64.

See reviews... See all...

Cited by 25 PubMed Central articles

Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice. [Probiotics Antimicrob Proteins...]
Antagonistic Action of Lactobacilli and Bifidobacteria in Relation to Staphylococcus aureus and Their Influence on the Immune Response in Cases of Intravaginal Staphylococcosis in Mice.
Lazarenko L, Babenko L, Sichel LS, Pidgorskyi V, Mokrozub V, Voronkova O, Spivak M. Probiotics Antimicrob Proteins. 2012 Jun; 4(2):78-89. Epub 2012 Feb 25.
Review Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. [Exp Diabetes Res. 2012]
Review Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S, et al. Exp Diabetes Res. 2012; 2012:902917. Epub 2012 May 3.
Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4. [BMC Microbiol. 2012]
Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.
Karlsson M, Scherbak N, Reid G, Jass J. BMC Microbiol. 2012 Jan 22; 12:15. Epub 2012 Jan 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Oral probiotics can resolve urogenital infections.
Oral probiotics can resolve urogenital infections.
FEMS Immunol Med Microbiol. 2001 Feb ;30(1):49-52.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Oral probiotics can resolve urogenital infections.

Source

Abstract

MeSH Terms

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 25 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information